title: The JAK2(V617F) mutation may be present several years before the occurrence of overt myeloproliferative disorders.
authors.forename: C
authors.initials: C
authors.lastname: Bellanné-Chantelot
authors.forename: P
authors.initials: P
authors.lastname: Jego
authors.forename: P
authors.initials: P
authors.lastname: Lionne-Huyghe
authors.forename: M
authors.initials: M
authors.lastname: Tulliez
authors.forename: A
authors.initials: A
authors.lastname: Najman
mesh_terms: D005192:Family Health; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D020125:Mutation, Missense; D009196:Myeloproliferative Disorders / Q000209:etiology*; D013997:Time Factors
chemical_list: D053614:Janus Kinase 2